Zettl, Rolf (Helmholtz 201502 Managing Director) |
Managing Director |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Zettl, Sophie (Ygion Biomedical 202405 CBO formerly CEBINA 202003 before Arsanis + MedImmune/AZ) |
Business Development Manager / Strategy Manager |
Ygion Biomedical GmbH |
Austria |
Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) |
Chief Executive Officer (CEO) |
Valneva (Group) |
Austria |
Zetzmann-Krien, Diane (Bremen (govt) 201110 Managing Director of Bremer Aubau-Bank GmbH) |
Managing Director |
Bremen (govt region) |
Germany |
Zeyer, Denis (Novalix 201011 CEO) |
Chief Executive Officer (CEO) |
Novalix (Group) |
France |
Zeyfang, D. |
n. a. |
DaimlerChrylser (Group) |
Germany |
Zhang, Ingrid (Novartis 201904 President Novartis Pharmaceuticals China) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
China |
Zhang, Jay Z. (Shuwen Biotech 201512 CEO) |
Chief Executive Officer (CEO) |
Shuwen Biotech Co. Ltd. |
China |
Zhang, Lei (Univ Bremen 200603) |
n. a. |
University of Bremen |
Germany |
Zhang, Peizhuo (Qiagen 201305– General Manager of Qiagen (Suzhou) Translational Medical Center) |
General Manager (management) |
Qiagen (Group) |
China |
Zhang, Weiyi (Boehringer 202007 Head of External Innovation Hub China) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
China |
Zhang, Yulian (Triastek 202407 VP of Global Business Development) |
Business Development Manager / Strategy Manager |
Triastek (Group) |
China |
Zhang, Zeeman (Beijing Clear Biotech 201509 Director) |
President/Director/Head Business Group/Unit/Division |
Beijing Clear Biotech Co., Ltd. (BCB) |
China |
Zhao, Xing (ReLive 202301 CEO + Founder) |
Chief Executive Officer (CEO) |
ReLive (Group) |
|
Zheleznyi, George (Cultimate Foods 202404 Managing Director + Co-Founder) |
Managing Director |
Cultimate Foods GmbH |
Germany |
Zheng, Jerry (Körber 202409 Managing Director of Körber Business Area Pharma China) |
Managing Director |
Körber (Group) |
Germany |
Zheng, Li-Mou (Amoy Diagnostics 201607 CEO) |
Chief Executive Officer (CEO) |
Amoy Diagnostics Co., Ltd. (AmoyDx) |
China |
Zhou, Ding (Zion Pharma 202305 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Zion Pharma Ltd. (CN) |
China |
Zhou, Frank (Grand Pharmaceutical 202112 CEO) |
Chief Executive Officer (CEO) |
Grand Pharmaceutical Group Ltd. (Grand Pharma, GP) |
China |
Zhou, Jack (B&W Tek LLC 201807 CEO) |
Chief Executive Officer (CEO) |
Metrohm (Group) |
United States (USA) |
Zhou, Li (TxCell 201610– VP Cell Engineerung before ZMKS + Novartis Biologics Center MA + MGH + Cereon Genomics) |
Researcher (industry) |
Sangamo (Group) |
France |
Zhou, Tingting (Novogene 202312 VP of Novogene Europe) |
President/Director/Head Business Group/Unit/Division |
Novogene (Group) |
United Kingdom (GB) |
Zhou, WeiQing (LifeMine Therapeutics 202102 COO + Co-Founder + FogPharma COO + Co-Founder) |
Chief Operating Officer (COO) |
LifeMine Therapeutics (Group) |
United States (USA) |
Zhu, John (DualityBio 202304 CEO + Founder formerly 6 Dimensions Capital) |
Chief Executive Officer (CEO) |
Duality Biologics (Suzhou) Co. Ltd. (DualityBio) |
China |
Zhu, Ted (Fosun Group 201407 General Manager of Fosun Diagnostics division) |
General Manager (management) |
Fosun (Group) |
China |
Zhukovsky, Eugene (Biomunex 201510– CSO before Affimed + Boehringer Ingelheim Pharmaceuticals + Xencor) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biomunex Pharmaceuticals SAS |
France |
Zickgraf, Patrik (Ganzimmun Diagnostics 202112 CEO) |
Chief Executive Officer (CEO) |
Ganzimmun Diagnostcs AG (GD) |
Germany |
Ziebig, Marlene (Gulde Hengelhaupt Ziebig & Schneider 200809 Berlin) |
n. a. |
Grünecker, Kinkeldey, Stockmair & Schwanhäusser GbR |
Germany |
Ziebolz, Burkhard (Roche Diagnostics 200503) |
n. a. |
Roche (Group) |
Germany |
Ziegelbauer, Karl (Almirall 202205 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Almirall (Group) |
Spain (España) |
Ziegenhagen, Andreas (Dentons 201412 Managing Partner Germany) |
Managing Partner |
Dentons (Group) |
Switzerland |
Ziegler, Andreas (Genetics Co 200106– CFO before Deloitte & Touche) |
Chief Financial Officer (CFO) |
Genetics Company Inc., The |
Switzerland |
Ziegler, Markus (Bruker 202305 Senior Director + Head of Group Marketing at Bruker BioSpin) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
Ziegler, Michael (PVT Probenverteiltechnik GmbH 201103 Managing Director) |
Managing Director |
Roche (Group) |
Germany |
Ziegler-Jöns, Alexander (Jacobs Uni 201311 Science + Technology Transfer + Vivace GmbH 201311 Managing Director) |
IP Manager |
Schaffhausen Institute of Technology (SIT) |
Germany |
Ziehr, Holger (Fraunhofer 201504 Head of Dept of Pharmaceutical Biotechnology at ITEM) |
Researcher (university / research institute) |
Fraunhofer (Group) |
Germany |
Zienicke, Benjamim (BIOPRO Baden-Württemberg GmbH 201110– Project Manager Biotechnology) |
n. a. |
Baden-Württemberg (govt region) |
Germany |
Zieziula, Gary (Merck (DE) 201601–201812 Head Biopharma North America joined 2014 before MSD + BMS + Roche LEFT 12/18) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
Zilch, Christian Frank (Magna Diagnostics GmbH 201512 Managing Director) |
Managing Director |
|
|
Zilian, Olav (Medigene 201601– SVP Corporate Development before Helvea SA + ISREC) |
Business Development Manager / Strategy Manager |
Medigene (Group) |
Germany |
Zillikens, Stefanie (High-Tech Gründerfonds 201206 Marketing + Communciations Manager) |
Public Relations Manager / Investor Relations Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Zilliox, Patricia (Eyevensys 201712– CEO joined board 201605 before Foundation Fighting Blindness + Alcon) |
Chief Executive Officer (CEO) |
Eyevensys (Group) |
France |
Zimmer, David (Coparion 201701 Managing Director) |
Managing Director |
Germany (govt) |
Germany |
Zimmer, Franz-Josef (Grünecker, Kinkeldey, Stockmair & Schwanhäusser 200809 Munich) |
n. a. |
Grünecker, Kinkeldey, Stockmair & Schwanhäusser GbR |
Germany |
Zimmer, Thomas (AMP Biosimilars 201505– Supervisory Board Chairman formerly at Boehringer Ingelheim) |
Supervisory Board Member |
AMP Biosimilars AG |
Germany |
Zimmerman, Zachary A. (Forge Therapeutics 201612 CEO) |
Chief Executive Officer (CEO) |
Forge Therapeutics Inc. |
United States (USA) |
Zimmermann, Bastian (Biaffin 201110 Managing Director) |
Managing Director |
Biaffin (Group) |
Germany |
Zimmermann, Cyrill (Bellevue Group 201409 CEO of Adamant Biomedical Investments AG) |
Chief Executive Officer (CEO) |
Bellevue (Group) |
Switzerland |
Zimmermann, Dirk (Biocartis 201905– Global Head Pharma Collaborations + Partnering before Roche Diagnostics + Qiagen) |
Business Development Manager / Strategy Manager |
Biocartis (Group) |
Belgium |
Zimmermann, Elke |
n. a. |
Bremen (govt region) |
Germany |
Zimmermann, Frank (Biomax Informatics 201710 Director Business Development) |
Business Development Manager / Strategy Manager |
Biomax (Group) |
Germany |
Zimmermann, Heiko (Fraunhofer 201402 Head of Fraunhofer IBMT) |
President/Director/Head Business Group/Unit/Division |
Fraunhofer (Group) |
Germany |
Zimmermann, Holger (AiCuris 202304– Chief Research + Development Officer before CEO before CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Zimmermann, Jens (Adrenomed 2017– CMO before Vanda Pharmaceuticals + Roche + InterMune + Pfizer + Shire + Jerini) |
Chief Medical Officer (CMO) |
Adrenomed AG |
Germany |
Zimmermann, Julia (Terraplasma 202210 Managing Director (CEO)) |
Managing Director |
Terraplasma (Group) |
Germany |
Zimmermann, Philip (Nebion 201801 CEO) |
Chief Executive Officer (CEO) |
Immunai (Group) |
Switzerland |
Zimmermann, Ralf (Helmholtz-Zentrum München + Univ Rostock) |
Professor |
University of Rostock |
Germany |
Zimmermann, Sabrina (BMG Labtech 201110 Sales Assistant BMG Labtech GmbH) |
Sales Manager / Marketing Manager |
BMG Labtech (Group) |
Germany |
Zimmermann, Sven (Novimmune 201609– CFO before Auris Medical + PregLem + UBS Investment Bank) |
Chief Financial Officer (CFO) |
Novimmune S.A. |
Switzerland |
Zinggrebe, Achim (Syneed Medidata GmbH 201305 Managing Director) |
Managing Director |
Syneed Medidata GmbH |
Germany |
Zink, Barbara (Basilea 201109 Head Corporate Development) |
Business Development Manager / Strategy Manager |
Basilea (Group) |
Switzerland |
Zinke, Holger (BRAIN 201507– Supervisory Board Member before CEO) |
Supervisory Board Member |
BRAIN Biotech (Group) |
Germany |
Zinsser, Werner (Zinsser Analytic 200808 Managing Director) |
Managing Director |
KKR (Kohlberg Kravis Roberts) (Group) |
Germany |
Zinsser-Noethen, Wiebke (Zinsser Analytic 200809) |
Sales Manager / Marketing Manager |
KKR (Kohlberg Kravis Roberts) (Group) |
Germany |
Zinzalla, Vittoria (Boehringer 202402 Global Head of Oncology Translational Medicine + Clinical Pharmacology) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
Zirngibl, Carmen (DCZ Executive Search 202312 + FS Life Science Investment) |
Managing Partner |
DCZ Executive Search GmbH |
Germany |
Zitna , Andrea (Speedinvest 202212 Partner for Health Investments) |
Partner (venture partner) |
Speedinvest (Group) |
Austria |
Ziwica, Marcel (Zur Rose Group 202007 CFO) |
Chief Financial Officer (CFO) |
Zur Rose Group (Group) |
Switzerland |
Zobel, Peter Hanns (Bayern (govt) 1995–202403 Managing Director at IZB LEFT 3/24) |
Managing Director |
Bavaria (govt region) |
Germany |
Zohar, Daphne (Seaport Therapeutics 202404– CEO + Co-Founder before PureTech Health CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Seaport Therapeutics (US) |
United States (USA) |
Zolghadr, Kourosh (ChromoTek 201403 Head of RnD) |
Research & Development Manager |
Proteintech (Group) |
Germany |
Zollner, Stanislava (Helmholtz 202008 at Ascenion GmbH) |
Public Relations Manager / Investor Relations Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
Zoltobrocki, Manfred (PKCie 200604– Senior Consultant before Lux Biosciences GmbH + Epidaurus AG) |
Consultant (economic/technology) |
PKCie – Prof. Köpper & Cie Management Consultants GbR |
Germany |
Zorbas, Haralabos (Bayern (govt) 201307 Managing Director of IBB Netzwerk GmbH) |
Managing Director |
Bavaria (govt region) |
Germany |
Zori, Ron (Essential Capital 202311) |
Investment Manager |
Essential Capital (US, NY) |
United States (USA) |
Zoro, Barney (Sartorius 201803 ambr Product Manager at SSB) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
Zsebo, Krisztina (Celladon Corp 201411 CEO) |
Chief Executive Officer (CEO) |
Celladon Corporation |
United States (USA) |
Zuber, Johannes (IMP Vienna 2011– Group Leader + Quantro Therapeutics 202007 Co-Founder + Scientific Advisor) |
Researcher (university / research institute) |
Boehringer Ingelheim (Group) |
Austria |
Zucchelli, Piero (Andrew Alliance 201806 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Waters (Group) |
Switzerland |
Zucker, Maximilian (Numares 201702 Executive Board Member + Head RnD) |
Board member, executive |
Numares (Group) |
Germany |
Zuckerman, Linda (Evotec 202209 EVP Global Head Biotherapeutics at Just – Evotec Biologics) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
United States (USA) |
Zuliani, Vincent (GenoSafe 201611 Business Development Director) |
Business Development Manager / Strategy Manager |
GenoSafe SAS |
France |
Zumbansen, Markus (Ayoxxa 201407– VP RnD before Miltenyi Biotec) |
Research & Development Manager |
Ayoxxa (Group) |
Germany |
Zumbrum, Michael (AllPure Technologies 201404 President) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
United States (USA) |
Zundel, Stefan (Dopavision 201809– Managing Director + Co-Founder) |
Managing Director |
Dopavision GmbH |
Germany |
zur Hausen, Harald |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
zur Hausen, Jan Dirk (Bergmann zur Hausen 201210 Managing Director + Co-founder) |
Managing Director |
Bergmann zur Hausen & Cie. GmbH |
Germany |
Zurdo, Jesús (Rentschler 201911 SVP Innovation + Venture Partnerships) |
n. a. |
Rentschler (Group) |
Germany |
Zurek Gabriela (Bruker Biosciences 2006 Bruker Daltonik GmbH Application Scientist) |
n. a. |
Bruker (Group) |
Germany |
Zurlo, Alfredo (Glycotope 201604– CMO before Mologen 201304– CMO before Roche + EORTC) |
Chief Medical Officer (CMO) |
Glycotope (Group) |
Germany |
Zwanziger, Ron (Alere/Inverness Medical 200603–201406 CEO RESIGNED 7/14) |
Chief Executive Officer (CEO) |
Abbott (Group) |
United States (USA) |
Zwick, Jordan (Mirador Therapeutics 202403 CBO formerly InflaRx before Salix + Medtronic) |
Business Development Manager / Strategy Manager |
Mirador Therapeutics Inc. |
United States (USA) |
Zwicker, Jörk (ZSP Patentanwälte 201704 Partner beore Boehmert & Boehmert) |
Patent Attorney |
ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) |
Germany |
Zwyer, Alex (NLS Pharmaceutics 202410 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
NLS Pharmaceutics Ltd. (CH) (NLSP) |
Switzerland |
Zündorf, Christin (TQ Therapeutics 202407 Business + Commercial) |
Business Development Manager / Strategy Manager |
TQ Therapeutics GmbH |
Germany |
Zündorf, Peter (Schering 2005– before Aventis Pharma before RPR + Bayer) |
n. a. |
Bayer (Group) |
Germany |
Zünkeler, Martin (Kairos GmbH 201203 Managing Director) |
Managing Director |
Iqvia (Group) |
Germany |
Zypries, Brigitte (Germany (govt) 200809 Minister of Justice) |
Minister |
Germany (govt) |
Germany |
Zywottek, Walter W. (Merck KGaA –200807 before VWR president and CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
Zätzsch, Jörg (CMS Hasche Sigle 200809 Berlin) |
Attorney / Lawyer |
CMS (Group) |
Germany |